Live feed
Filing
SC 13G/A
SC 13G/A0000902664-21-001018·HIGHBRIDGE CAPITAL MANAGEMENT LLC
Schedule 13G ownership disclosure
Protalix BioTherapeutics Inc
Security class unavailable · CUSIP: 74365A309
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,063,194
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-21-001018
- Form type
- SC 13G/A
- Filer
- HIGHBRIDGE CAPITAL MANAGEMENT LLC
- CIK
- CIK 919185
- Filed
- Feb 09, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership